NRX PharmaceuticalsNRXP
13F holders, Q4 2025 (December 31)28holders +4
6new positions
3sold out
1famous investor
$2.71avg. 13F price*
At the end of Q4 2025, 28 institutions reported holding NRX Pharmaceuticals Inc. (NRXP) in their 13F filings, up 4 from Q3 2025. 6 opened new positions and 3 sold out. The largest holders were Anson Funds Management LP ($8.2M), Vanguard Group Inc. ($2.0M) and Commonwealth Equity Services, LLC ($994K). One famous investor held it Steve Cohen (0.0% of Point72 Asset Management's portfolio).
- Company
- NRX Pharmaceuticals Inc.
- CUSIP
- 629444209
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 6 | $1.5M |
| Exits | 3 | $1.0M |
All 13F filers, Q3 2025 → Q4 2025: 1,826,028 shares bought and 562,141 shares sold, net +1,263,887 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 28 holders
| Anson Funds Management LP | 1.17% | Add +50.3% | 3,043,957 | $8.2M |
| Vanguard Group Inc. | 0.00% | Add +36.4% | 729,842 | $2.0M |
| Commonwealth Equity Services, LLC | 0.00% | New | 366,631 | $994K |
| AdvisorShares Investments LLC | 0.15% | Reduce -4.1% | 328,004 | $889K |
| Geode Capital Management, LLC | 0.00% | Add +17.8% | 218,866 | $593K |
| Bleakley Financial Group, LLC | 0.01% | New | 117,204 | $318K |
| State Street Corp. | 0.00% | Add +14.0% | 86,984 | $236K |
| BlackRock, Inc. | 0.00% | Add +26.4% | 82,654 | $224K |
| Global Retirement Partners, LLC | 0.00% | New | 39,300 | $107K |
| Jane Street Group, LLC | 0.00% | Reduce -48.1% | 38,065 | $103K |
| One Wealth Management Investment & Advisory Services, LLC | 0.11% | Add +35.3% | 37,873 | $103K |
| Northern Trust Corp. | 0.00% | Add +1.2% | 28,947 | $78K |
| Chicago Partners Investment Group LLC | 0.00% | Reduce -20.4% | 33,421 | $73K |
| Two Sigma Investments, LP | 0.00% | Reduce -66.7% | 17,436 | $47K |
| Point72 Asset Management | 0.00% | New | 15,979 | $43K |
| Sjbenen Advisory, LLC | 0.04% | — | 15,000 | $41K |
| Ethos Financial Group, LLC | 0.00% | No change | 11,900 | $32K |
| Morgan Stanley | 0.00% | Reduce -9.5% | 10,029 | $27K |
| UBS Group AG | 0.00% | Reduce -97.7% | 3,538 | $10K |
| Bank of America Corp. | 0.00% | Reduce -4.7% | 3,239 | $9K |
| SBI Securities Co., Ltd. | 0.00% | No change | 2,500 | $7K |
| Wells Fargo & Company | 0.00% | No change | 2,000 | $5K |
| Royal Bank of Canada | 0.00% | New | 2,000 | $5K |
| Osaic Holdings, Inc. | 0.00% | Reduce -91.7% | 90 | $243 |
| JPMorgan Chase & Co. | 0.00% | No change | 34 | $92 |
| Larson Financial Group LLC | 0.00% | No change | 22 | $60 |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -99.7% | 1 | $3 |
| Steward Partners Investment Advisory, LLC | 0.00% | New | 1 | $3 |
"% of holder's portfolio" is NRXP's weight in each manager's 13F, not the share of NRX Pharmaceuticals Inc. the manager owns.